EVALUATION OF NOVEL ANTIGENS

PhenoPath Laboratories evaluates cell lines, xenografts, normal and tumor tissue provided by investigators to assess the expression of specific antigens. In this regard, antibodies, either provided by the client, commercially available, or from our clinical bank, are utilized for antigen detection. Studies can also involve assessment of unique or recently identified molecules for expression in normal and tumor tissues.

EGF stimulated A431 cells showing positive submembranous staining for phospho-EGFR	Phospho-AKT expression with nuclear and cytoplasmic staining in LnCap xenograft